All products Quality & compliance Resources About Contact
Request a quote

Veterinary

Sourcing veterinary APIs: the regulatory layer most buyers under-scope

Veterinary actives carry an extra set of constraints that human-API playbooks miss: species-specific MRLs, feed-premix physical form, and a different definition of a clean file.

Published 2026-09-18 · Bioran Pharma technical desk

White veterinary boluses and medicated powder on a stainless steel tray
Animal-health solid dosage materials — illustrative photography

A veterinary API is not a human API with a different label. Sourcing teams that run the same qualification playbook often hit three problems late, when a dossier is already drafted.

1. Maximum residue limits drive the specification, not the monograph

For food-producing animals, the tolerable residue in meat, milk, eggs or honey sets a de facto impurity constraint that a pharmacopoeial monograph does not describe. A material can meet the monograph and still be awkward to register if a route-related impurity sits near a marker residue.

Ask the supplier for the route and for the impurity profile, then check it against the marker residue definition for your target species and market. This is a conversation to have before sample qualification, not after.

2. Physical form is a formulation decision, not a purchasing detail

Feed premix, oral drench, injectable and water-soluble powder need different particle size distributions. Premix uniformity depends on the API particle size matching the carrier; a micronised lot that works in a suspension can segregate in a premix. Specify D10/D50/D90 and the test method, and ask whether the supplier can hold that window across lots.

3. Species and region change the documentation pack

Veterinary filings vary more between markets than human ones. Expect to be asked for:

  • Target-animal safety data, often as a literature summary rather than new studies.
  • Withdrawal-period support — usually the marketing authorisation holder's responsibility, but the API impurity profile feeds into it.
  • Antimicrobial resistance statements for antibiotic actives, increasingly a registration requirement in the EU and in several Asian markets.
  • Feed-additive compliance where the product is administered via medicated feed, which brings additional manufacturing and cross-contamination controls.
Where buyers lose time: treating the veterinary dossier as a copy of the human one. The drug-substance section may look similar, but the safety and residue sections are built from different data, and the API supplier's documentation has to support both.

4. Cross-contamination control is a purchasing criterion

If your facility runs both human and veterinary products, or several species, segregation requirements affect which supplier you can use — some sites are dedicated to a single class. Ask for the site's cross-contamination policy and the cleaning validation summary. A supplier who cannot answer precisely is a supplier who has not been audited on this point before.

What to send with a veterinary enquiry

  • Species and production type (food-producing or companion animal).
  • Dosage form and, for premix, the carrier system.
  • Target markets and the registration route in each.
  • Required particle size window, if already fixed by your formulation.

These four items let a supplier answer with a real specification rather than a catalogue extract — and cut a week out of the qualification cycle.


This note describes general industry practice. It is not regulatory advice and does not replace the requirements of your destination authority or your own quality system.

Back to all resources

Need a specification, a sample or a price?

Send the CAS number, the grade your dossier requires and the annual volume. You will get a technical reply from the product desk — not a sales autoresponder.